199
Participants
Start Date
September 20, 2021
Primary Completion Date
October 4, 2023
Study Completion Date
October 4, 2023
NFX-179 gel
NFX-179 topical gel is the active investigational product being studied
Vehicle gel
NFX-179 vehicle gel is the placebo comparator for this study
Sadick Research Group, LLC, New York
Skin Search of Rochester, Inc., Rochester
Derm Dox Center for Dermatology, Sugarloaf
Children's National Hospital, Washington D.C.
The Johns Hopkins School of Medicine, Baltimore
The Education & Research Foundation, Inc., Lynchburg
Wake Forest School of Medicine, Winston-Salem
University of Florida, Gainesville
Apex Clinical Research Center, LLC, Mayfield Heights
Dawes Fretzin Clinical Research Group, Indianapolis
Minnesota Clinical Study Center, New Brighton
Northshore University HealthSystem, Evanston
Skin Specialists, P.C., Omaha
Northwest Arkansas Clinical Trials Center, PLLC, Rogers
Dermatology Treatment and Research Center, Dallas
UTHealth McGovern Medical School, Houston
University of Utah, Salt Lake City
Children's Hospital Los Angeles, Los Angeles
University Clinical Trials, Inc., San Diego
Center for Dermatology Clinical Research, Inc., Fremont
Oregon Health & Science University, Portland
University of Arkansas for Medical Sciences, Little Rock
Massachusetts General Hospital, Boston
Lead Sponsor
NFlection Therapeutics, Inc.
INDUSTRY